Impingement Syndrome Market Size was valued at USD 1.5 Billion in 2023. The Global Impingement Syndrome industry is projected to grow from USD 1.6 Billion in 2024 to USD 2.73 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2024 - 2032). Impingement syndrome or subacromial impingement occurs when the tendons of the rotator cuff muscles become impinged and inflamed as they pass through the subacromial space.
There are two major types of this disease, structural impingement and functional impingement. Different types of diagnosis methods like bone spurs, rotator cuff injury, labral injury, shoulder instability, biceps tendinopathy and scapula dysfunction can be used to diagnose this disorder. Increasing prevalence of orthopedic diseases, rising geriatric population and changing lifestyle have boosted the growth of the market. According to International Osteoporosis Foundation, worldwide osteoporosis causes more than 8.9 million fractures annually. Moreover, increasing healthcare expenditure and government initiatives for research and development have fuelled the market growth. However, high cost surgeries, and lack of awareness about this disorder may slow the growth of the market.
The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.
On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.
On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is subsegmented into arthroscopic surgery, open surgery and others. On the basis of end user, the market is segmented into hospitals, physical therapists, and others.
Some of the key players in this market are:
The America dominates the global impingement syndrome market owing to the presence of huge geriatric population, increasing number of patient suffering from orthopedic diseases and increasing healthcare expenditure. Moreover, high healthcare speeding is another major factor contributing to the market growth.
Europe accounts for the second largest impingement syndrome market across the globe owing to increasing government support for research & development, increasing investment in healthcare, and well developed healthcare sector.
Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of chronic diseases, huge population base and rapidly developing economy drives the growth of the market in this region.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | USD 2.73 Million |
| CAGR | 7.80% |
| Base Year | 2021 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types, Diagnosis, treatment, and End users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US) |
| Key Market Opportunities | · In America, high healthcare speeding is major factor contributing to the market growth · In Asia Pacific, increasing government support for research & development and rapidly developing economy drives the growth of the market |
| Key Market Drivers | · Increasing prevalence of orthopedic diseases · Rising geriatric population and changing lifestyle |
Impingement Syndrome Market Highlights:
Frequently Asked Questions (FAQ) :
Global impingement syndrome market is projected to grow at approximately 7.80% CAGR during the assessment period (2024-2032).
Increasing healthcare expenditure and government initiatives for R&D, are major tailwinds pushing the growth of the global impingement syndrome market.
High cost surgeries and lack of awareness about this disorder are major growth impeders for the global impingement syndrome market.
North America holds the largest share in the global impingement syndrome market, followed by Europe and the Asia Pacific, respectively.
ATOS Klinik Heidelberg GmbH & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), DePuy Synthes (US), Stryker Corporation (US), Smith & Nephew (UK), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Immediate Media Company Ltd. (US), and Abbott (US), are some of the top players operating in the global impingement syndrome market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
